Hospital Universitario, Salamanca

Salamanca 37007

0 studies enrolling now · 2 studies all time

What they study most

MDS, Multiple Myeloma, Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts

Studies at this site

• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
• Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma — Completed